Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

19 Dec 2023 15:28

RNS Number : 3543X
Maven Income and Growth VCT 5 PLC
19 December 2023

Maven Income and Growth VCT 5 PLC (the Company)

Issue of Equity

On 13 October 2023, the Company launched an offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £5 million, with an over-allotment facility for up to a further £2.5 million (the Offer).

Pursuant to the Offer, a total of £1,233,791 of valid applications were received in the period from 13 October 2023 up to and including 9.00am on 13 December 2023. In respect of the 2023/2024 tax year, £1,211,541 of valid applications were received and, as a result, the Company has issued and allotted 3,680,581 new Ordinary Shares on 19 December 2023. In accordance with the allotment formula set out in the prospectus for the Offer, the offer prices at which the shares were issued were in the range of 32.53p to 33.89p per Ordinary Share and, as a result, the number of Ordinary Shares now in issue is 199,080,292. Therefore, the total number of voting rights in the Company is 199,080,292.

In respect of this allotment, an application will be made by the Company to the FCA and to the London Stock Exchange for the new Ordinary Shares so issued to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that the admission of the new Ordinary Shares will become effective, and dealings will commence, on or around 4 January 2024.

The above statement of Voting Capital may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

The Board of the Company intends that a further allotment in respect of applications for the 2023/2024 tax year will take place shortly after the end of the Early Investment Incentive period, being 5.00pm on 31 January 2024.

For further information, please contact:

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLP

Secretary

19 December 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IOENKCBBPBDDOBD
Date   Source Headline
26th Aug 202210:14 amRNSIssue of Equity
22nd Aug 20229:36 amRNSStatement re Dividend Investment Scheme
11th Aug 20224:47 pmRNSTransaction in Own Shares
25th Jul 20227:00 amRNSHalf-year Report
12th Jul 202212:40 pmRNSUnaudited Net Asset Value and Dividend Declaration
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
4th May 20229:28 amRNSIssue of Equity - Dividend Investment Scheme
3rd May 20225:07 pmRNSTransaction in Own Shares
28th Apr 20224:37 pmRNSStatement re Dividend Investment Scheme
27th Apr 202211:10 amRNSNet Asset Value(s)
26th Apr 20221:01 pmRNSResult of AGM
10th Mar 20224:57 pmRNSAnnual Financial Report
10th Mar 20227:00 amRNSRelated Party Transaction
23rd Feb 20223:57 pmRNSTransaction in Own Shares
17th Feb 20224:45 pmRNSTransaction in Own Shares
16th Feb 20223:56 pmRNSTransaction in Own Shares
9th Feb 20224:51 pmRNSTransaction in Own Shares
4th Feb 20224:26 pmRNSStatement re NAV and Dividend
26th Nov 202111:13 amRNSDirector/PDMR Shareholding
26th Nov 202111:11 amRNSDirector/PDMR Shareholding
26th Nov 202110:50 amRNSIssue of Equity
22nd Nov 202110:54 amRNSStatement re Dividend Investment Scheme
20th Oct 20211:00 pmRNSDividend Declaration
8th Oct 20214:03 pmRNSTransaction in Own Shares
6th Oct 202111:23 amRNSNet Asset Value(s)
20th Sep 20214:57 pmRNSStatement re Change of Registrar
10th Sep 20219:59 amRNSDirector/PDMR Shareholding
10th Sep 20219:57 amRNSDirector/PDMR Shareholding
10th Sep 20219:31 amRNSIssue of Equity
7th Sep 20213:09 pmRNSStatement re Dividend Investment Scheme
10th Aug 20214:31 pmRNSHalf-year Report
5th Aug 20219:17 amRNSStatement re NAV and Interim Dividend
7th May 20213:54 pmRNSTransaction in Own Shares
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:03 pmRNSIssue of Equity
5th May 202112:56 pmRNSTransaction in Own Shares
4th May 20214:01 pmRNSStatement re Dividend Investment Scheme
4th May 20213:54 pmRNSDirector/PDMR Shareholding
4th May 20213:25 pmRNSIssue of Equity
27th Apr 20211:46 pmRNSNet Asset Value(s)
27th Apr 20211:17 pmRNSResult of AGM
6th Apr 20217:00 amRNSIssue of Equity
1st Apr 202110:33 amRNSStatement re Offer for Subscription
23rd Mar 20213:41 pmRNSPublication of Suppl.Prospcts
15th Mar 20213:37 pmRNSAnnual Financial Report
3rd Mar 20213:05 pmRNSHolding(s) in Company
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.